These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4143476)

  • 1. [Clinical evaluation of indium bleomycin in the scanning of neoplasm].
    Bennett LR
    Gac Med Mex; 1974 Feb; 107(2):174-8. PubMed ID: 4143476
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of indium bleomycin-111 in the scintillography of tumours].
    Bennett LR
    Gac Med Mex; 1974 Feb; 107(2):174-8. PubMed ID: 4134004
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
    Grove RB; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
    [No Abstract]   [Full Text] [Related]  

  • 4. [Positive tumor scintigraphy. II. Clinical results with 111In-bleomycin].
    Weiss ML; Deckart H
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):378-86. PubMed ID: 82977
    [No Abstract]   [Full Text] [Related]  

  • 5. [Affinity of 111In-bleomycin for malignant tumors (author's transl)].
    Akiba H; Kakehi H; Kawana M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Mar; 34(3):162-8. PubMed ID: 4137371
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleomycin 111-I scanning: a new technique for detecting subclinical metastatic cancer.
    Silverstein MJ; Verma RC; Touya JJ; Bennett LR; Morton DL
    Surg Forum; 1973; 24():129-31. PubMed ID: 4142814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of scintigraphy for neoplasms with 57 Co-bleomycin].
    Watanabe K; Kawahira K; Nakayama C; Kamoi I; Matsuura K
    Rinsho Hoshasen; 1975 Jun; 20(6):495-502. PubMed ID: 51946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radioisotope scanning of neoplasms 5. 111-In-bleomycin].
    Machida K
    Rinsho Hoshasen; 1975 Oct; 20(11):1041-2. PubMed ID: 53300
    [No Abstract]   [Full Text] [Related]  

  • 9. Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.
    van de Poll MA; Versluis A; Rasker JJ; Jurjens H; Woldring MG
    Nuklearmedizin; 1976 Apr; 15(2):86-90. PubMed ID: 58409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 131-I-CEA antibody as a tumor scanning agent.
    Hoffer PB; Lathrop K; Bekerman C; Fang VS; Refetoff S
    J Nucl Med; 1974 May; 15(5):323-7. PubMed ID: 4132666
    [No Abstract]   [Full Text] [Related]  

  • 11. [First experiences with radioisotope scanning with bleomycin-CO 57 ].
    Laconi A; Gallo G; Torina G
    Minerva Med; 1973 Mar; 64(16):747-50. PubMed ID: 4122260
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of indium 111-labeled bleomycin tumor scanning to predict response to bleomycin (NSC-125066) treatment.
    Jones SE; Salmon SE; Durie BG
    Cancer Chemother Rep; 1974; 58(5 Pt 1):733-5. PubMed ID: 4138967
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleomycin as a 99mTc carrier in tumor visualization.
    Lin MS; Goodwin DA; Kruse SL
    J Nucl Med; 1974 May; 15(5):338-42. PubMed ID: 4132667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic value of labeled bleomycin in epithelial tumors].
    Martinez Morillo M; Gil Gayarre M
    J Radiol Electrol Med Nucl; 1975; 56 suppl 1():383-5. PubMed ID: 60489
    [No Abstract]   [Full Text] [Related]  

  • 15. [First experiences in scansioscintigraphy with bleomycin Co 57].
    Laconi A; Gallo G; Torina G
    Minerva Med; 1973 Mar; 64(16):747-50. PubMed ID: 4124963
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis of malignant neoplasms and their extension using 57 Co labelled bleomycin].
    Nouel JP; Robert J; Witz H; Mammo L; Gest J; Gailliard P; Desgrez A; Vergnes R; Bru A; Renault H
    Strahlentherapie Sonderb; 1972; 72():504-12. PubMed ID: 4121633
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of data processing of scans to measurements of the uptake and distribution of tumour-localizing agents.
    Lavender JP; Merrick MV; Williams ED
    J Physiol; 1973 Jun; 231(2):80P. PubMed ID: 4124413
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical evaluation of indium-111 bleomycin as a tumor-imaging agent.
    Lilien DL; Jones SE; O'Mara RE; Salmon SE; Durie BG
    Cancer; 1975 Apr; 35(4):1036-49. PubMed ID: 46776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparation of indium-111 labelled bleomycin for tumour localisation.
    Thakur ML
    Int J Appl Radiat Isot; 1973 Jun; 24(6):357-9. PubMed ID: 4124881
    [No Abstract]   [Full Text] [Related]  

  • 20. 111-In-labelled bleomycin; clinical experience as a diagnostic agent in tumours of the thorax and abdomen.
    Merrick MV; Lavender JP; Poole GW; Stradling P; Thakur ML; Walter LH
    Br J Radiol; 1975 Apr; 48(568):279-85. PubMed ID: 48396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.